objective To assess the effectiveness of the WHO syndromic algorithm in the management of vaginal discharge among women of reproductive age in Dakar.
Introduction
Reproductive tract infections (RTIs), including sexually transmitted infections (STIs), are a major public health problem worldwide, particularly in developing countries. The number of new cases of the three main curable STIs (Chlamydia trachomatis, Neisseria gonorrhoeae [NG] and Trichomonas vaginalis [TV]) globally is estimated to be 170 million per year among women of reproductive age, with around 20% of these infections occurring in Africa alone [1] . Despite this enormous incidence of STIs, endogenous infections (vulvovaginal candidiasis and bacterial vaginosis [BV] ) remain the most frequent type of RTI [2] .
Late diagnosis and effective treatment of RTIs in women may lead to serious complications and sequelae, including pelvic inflammatory diseases (PIDs), chronic pelvic pain, infertility, spontaneous abortion, stillbirth, low birth weight and neonatal infections [2] [3] [4] . Case finding, access to care and improved case management are the main priorities in controlling STIs to interrupt transmission and prevent complications and sequelae [5] . However, case identification through aetiological diagnosis is a time-and resource-consuming procedure, which can be difficult in developing countries considering the paucity of laboratories, adequate equipment and trained personnel [5] . Taking these factors into consideration, WHO recommends a syndrome-based approach for the management of STI patients using simple clinical flow charts that may facilitate early diagnosis and treatment [6] (Figure 1 Although the aforementioned approach has been established to be practical and cost-effective in general [7, 8] , the performance of the syndromic algorithm is not sufficient to address the burden of STIs in Africa. Furthermore, results on the effectiveness of the vaginal discharge algorithm to detect these infections are conflicting, with some studies suggesting that the syndromic algorithm is a useful tool to manage vaginal infections [9] , while others [10, 11] arguing that it is inadequate for managing vaginal or cervical infections.
The ultimate objective of the syndromic management strategy is to reduce the burden of STIs through an effective treatment regimen that comprehensively covers the possible aetiological agents for a defined syndrome [12] . Therefore, the effectiveness of the vaginal discharge syndromic algorithm must be evaluated on the basis of the likelihood of providing correct treatment. Moreover, the performance of syndrome-based management of RTIs/STIs has shown variation based on geographical location [13] , which may be influenced in part by the prevalence of the infection, type of pathogens responsible for the infection, as well as the diagnostic method. Thus, for regions that promote the use of the WHO syndromic algorithm for the management of STIs, the approach must be validated and adapted at the country/local level [6] .
Thus this study aimed to assess the effectiveness of the WHO syndromic approach in the management of vaginal and cervical infections among symptomatic women of reproductive age living in Dakar.
Methods

Study design and samples
This prospective, cross-sectional study aimed to establish the laboratory-based prevalence of symptomatic lower genital tract infections among women visiting selected public health facilities in Dakar city, Senegal. A precisionbased sample size calculation with 95% confidence intervals (CIs) was used for the primary objective [14] . A table of sample size for different precision levels indicated that a sample of 260 women was adequate to describe any prevalence ranging from 10% to 90%. For instance, an expected prevalence range of 10% to 50% for a pathogen would have a precision range from 3.7% to 6.1%. However, the number of patients to be recruited was set at 300 to compensate for possible nonresponses.
Site and patient selection
As midwives were the first-line healthcare providers of women with complaints of vaginal symptoms in this region, they were the only eligible investigators. Consequently, selection of the study sites was based on the position of midwives as the main providers of reproductive health services for women with genital complaints. Two hospitals and four primary health centres were selected, representing the most important centres with regard to the number of patient visits with gynaecological complaints.
All new patients presenting at the study centres with complaints of vaginal symptoms were screened for eligibility. Consecutive patients at each study site who met the inclusion criteria were enroled. A patient was eligible if she met the following three inclusion criteria: age 18-49 years, with symptoms of vaginal discharge or itch (with/without burning, dyspareunia or bleeding between menstrual cycles/during sexual intercourse) and having signed the informed consent form. Patients were excluded if they were pregnant, were menstruating at the time of visit, reported using antibiotics or vaginal douches within the last 15 days, were sex workers, had an indication for gynaecological surgery or had symptoms indicating the development of PID, such as spontaneous pelvic pain or adnexal pain/pain during uterine mobilisation.
Data collection and procedures
Investigators were trained on the study procedures and data collection. Refresher training was also conducted on the WHO syndromic management of vaginal discharge.
Sociodemographic, obstetrical and behavioural data were collected at the time of inclusion using a structured standardised questionnaire. Physical and gynaecological examinations were also performed, including a speculum examination. All clinical information was recorded and transferred to the questionnaire. Patients were then referred to the laboratory of Le Dantec Hospital for collection of specimens. After a routine laboratory examination, samples were collected from the lateral and posterior vaginal fornix and endocervical canal according to the laboratory procedures.
Laboratory methods for detection of pathogens
The vaginal swabs were used for diagnosis of TV, candidiasis and BV, and a wet mount microscopic examination at 40 9 power was used for detection of TV. The result was considered positive if motile trichomonads were visible. Candida species (spp) were detected by culture. The vaginal specimen was inoculated into a medium containing Sabouraud agar with chloramphenicol and incubated for 24 h at 37°C. A diagnosis of candidiasis was made if vaginal colonisation by Candida spp was associated with vaginal symptoms suggestive of vaginal candidiasis, such as itching or erythema. If the diagnosis was positive, Candida albicans (CA) was then identified using a serum filamentation test. Gram stain examination and scoring using Nugent's criteria were performed for diagnosis of BV. The swab specimens were placed on a clean glass slide and heat fixed by passing the glass slide over the flame. BV was defined by a positive Nugent score of 7-10 in the presence of Gardnerella vaginalis (GV). The endocervical swab was used for diagnosis of Chlamydia trachomatis (CT) and NG. The diagnosis was performed using nucleic acid amplification tests (NAATs) involving the Cepheid Xpert CT/NG assay [15] . The assay detects the DNA of CT and NG, and the test is performed using a modular cartridge-based platform for testing each specimen by nucleic acid amplification. A positive result indicates a diagnosis of CT and NG.
Definitions of variables
Vaginal and cervical infections were defined according to aetiological and clinical approaches. The aetiological diagnosis was based on positive results of laboratory tests for identification/detection of pathogens. Identification of TV, CA or GV was defined as vaginal infection, and identification of CT or NG was defined as cervical infection.
The clinical definition was based on the WHO syndromic algorithm for the management of vaginal discharge [6] (Figure 1 ). For example, a woman presenting with vaginal discharge, vulval itching or burning in the absence of lower abdominal or cervical motion tenderness was considered positive for BV or trichomoniasis infection. Risk assessment for the syndromic definition of cervical infection (CT/NG infections) was also performed, and the risk was considered positive if the woman reported urethral discharge/dysuria in her male partner or presented simultaneously with at least two of the following criteria: (1) single, (2) age < 25 years, (3) >1 sexual partner or a new sexual partner in the last 3 months or sexual relationships with concurrent partners.
Syndromic management may be associated with any one of the following three scenarios: (a) missed treatment, resulting from a positive laboratory test with a negative syndrome-based diagnosis; (b) over-treatment, resulting from a negative laboratory test with a positive syndrome-based diagnosis and (c) correct treatment, resulting from a concordant positive or negative result on both the laboratory test and syndrome-based diagnosis.
Data analysis
Data were entered into the EpiData software, followed by a transfer to SPSS for analysis. A descriptive analysis of patient characteristics was performed using the sociodemographic data. The prevalence of infections was calculated with two-sided 95% CIs. Sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV) were calculated to assess the diagnostic accuracy of the syndromic approach. The proportions of missed treatment (1-Se), over-treatment (1-Sp) and correct treatment (per cent agreement) were also calculated to evaluate the effectiveness of the WHO syndromic algorithm. Furthermore, the degree of agreement between the syndromic approach and laboratory test was assessed using Cohen's kappa analysis. A kappa value ≥0.60 indicates adequate agreement [16] .
Ethical considerations
Eligible patients were informed by the midwives about the study objective and assessment methods. Written informed consent form was given by both the investigator and the patient before the administration of the anonymised questionnaire. This study was approved by the National Ethics Committee for Research in Health of the Ministry of Health and Social Action, Senegal (n°0 0000070 MSAS/DPRS/CNERS).
Results
From July to November 2015, consecutive patients at the study sites were screened, of whom 434 women were considered eligible as they met the inclusion criteria. Of these, 106 (24%) women were excluded for one of the following reasons: they were pregnant (n = 62), were menstruating at the time of visit (n = 5), were sex workers (n = 1), had used antibiotics within the last 15 days (n = 10), had an indication for gynaecological surgery (n = 2) or had symptoms indicating development of PID (n = 5) or were not willing to participate (n = 21). Another 52 patients were excluded because samples for laboratory test were not obtained. Thus, the remaining 276 patients were included in this analysis. The sociodemographic profile of the patients and the prevalence of selected pathogens responsible for lower genital tract infections are presented in Table 1 . The age of the patients ranged from 15 to 49 years, with a mean age of 31.5 AE 7.47: 47.5% of the patients were 25-34 years old and 34.8% were ≥35. Many patients (60.9%) had <7 years of education; 84.4% were married, of whom 70.6% were in a monogamous relationship. Table 3 summarises the Se, Sp, PPV and NPV of the syndromic approach in the management of vaginal and cervical infections using laboratory diagnosis as the reference standard. The syndromic approach showed a Se of 69% and a Sp of 9% in TV/GV management. Accordingly, 31% of infected women would not receive treatment (missed treatment), whereas 91% of non-infected women would be treated (over-treatment). The proportion of patients who would receive correct medical care for TV/GV was 51%. Se and Sp for CT/NG were 47% and 54%, respectively. Consequently, 53% of patients presenting with cervical infection due to CT/NG would not receive any treatment, while 46% of women who were free of infection would receive treatment for CT/ NG. With regard to CA, the results indicated that 51% of women would not be treated, 34% would be overtreated and 61% would be correctly managed overall. The analysis of concordance between the syndromic treatment approach and laboratory-based diagnosis showed a kappa value <0.20 ( Table 3 ), suggesting that there was no or only slight agreement between the methods.
Discussion
This prospective, cross-sectional study assessed the effectiveness of the WHO syndromic approach based on vaginal discharge in women from Dakar. The study included 276 symptomatic adult women. The prevalence of vaginal infections was high, while that of cervical infections was relatively low, affecting only around 5% of the women.
While the syndromic management algorithm has been extensively evaluated in different settings, many studies assessed its effectiveness using a questionable approach. For instance, using the vaginal discharge flow chart for treatment of a single organism, such as TV, might result in lowering the Se of the tool [17] ; in contrast, the approach could appear falsely more sensitive for the management of any infection (without distinction between vaginal and cervical infections) [18] . In this study, we assessed the effectiveness of the WHO syndromic algorithm using the likelihood of providing correct management for vaginal discharge.
The aim of the syndromic approach is to treat the main causative agent. In our study, only one of three women would have been offered an appropriate management for TV/GV infection using the WHO syndromic algorithm. In other words, applying the syndromic approach had no advantage over random presumption for TV/GV. In addition, while one of the advantages of the syndromic approach is to treat the patient immediately upon diagnosis, our results indicated that 31% of infected women would have been treated inappropriately, suggesting a moderate Se of the approach. The associated kappa value (0.08) was seven times inferior to the cut-off point, signifying no agreement of the syndromic approach with the laboratory diagnosis. Several studies have evaluated the effectiveness of the vaginal discharge algorithm in the management of TV/ GV infection. Rathod et al. [19] found an Se of 53% in women in South India, similar to our results, with more appropriate Sp (60%) than we did. A recent systematic review [13] examining the likelihood of providing correct treatment per the vaginal discharge flow chart showed that 52% of women were correctly managed for vaginal infection caused by TV/BV, which is consistent with our finding (51%).
Only seven cases of TV were found in this study, indicating that the most important component of the dual TV/GV infection was GV pathogens. BV occurs as a result of an overgrowth of pathogens including but not limited to GV and genital mycoplasmas [20] . Although the WHO syndromic approach does not include mycoplasma infections, these pathogens (Mycoplasma hominis and Ureaplasma urealyticum) were very common (89/276) and associated with TV/GV infection in 51/89 patients in our study. This may partly explain the poor predictive value of the algorithm in this population.
Vaginal candidiasis caused by CA was one of the most (29%) common infections. While the diagnosis of candida vaginitis can be made entirely clinically based on the symptoms and signs mentioned in the algorithm, the WHO approach did not succeed in identifying infected patients, as the Se was only 49%. Nevertheless, more than 60% of patients were correctly managed, which is encouraging and supports conclusions from other studies [9, 19] that found the algorithm very sensitive for the management of vaginal candidiasis. In this study, the prevalence of cervical infection caused by CT/NG was low (15/276) compared to that found in many developing countries [21] [22] [23] , which is not surprising as the patients in our study were less likely to have multiple or concurrent sexual partners [6] .
The performance of the WHO algorithm is expected to be relatively poor when the prevalence of CT/NG infection is low (<10%). This is consistent with our findings, with a Se and Sp of 47% and 54%, respectively, despite the use of both risk assessment and speculum examination. Using the algorithm, just over half of the patients would have been correctly managed, which resembles random treatment. If over-treatment of CT/NG infection can increase the risk of resistance to antibiotics, modify normal vaginal flora and raise treatment costs, wrong treatment also can lead to serious complications, such as PID and infertility. Therefore, in cases of suspected CT/ NG infections, laboratory diagnosis, where available, should be performed systematically.
A low performance of the WHO algorithm has also been reported in other settings [21, 23] . However, Zemouri et al. [13] assessed the benefit of the syndromic approach through a systematic review and meta-analysis and found that nearly 70% of the patients received correct treatment. This conflicting finding could be partly explained by the fact that the review included certain categories of the population, such as sex workers and pregnant women, who were excluded from our study.
Several factors need to be considered while interpreting our findings. First, the number of subjects is small because the sample size was calculated for determining the prevalence rate of main causative agents of vaginal and cervical infections, and the study was not specifically designed for assessing the effectiveness of the syndromic algorithm. Second, participating sites were limited to public health facilities, where midwives constituted the first-line managers of women with genital complaints. Thus, the representativeness of the population of interest within the sample may be questionable. Third, excluding women that were pregnant, sex workers or women practicing vaginal douching may have reduced the effectiveness of the algorithm. These groups are known to have a higher risk of vaginal and cervical infections, and the performance of the WHO algorithm is more likely to be poor in populations where the prevalence of infection is low. Fourth, laboratory methods used for the diagnosis of trichomoniasis are not the gold standards, and this may have contributed to lowering the observed prevalence of these infections, and therefore the performance of the algorithm. However, in clinical practice in developing countries, the diagnostic procedures performed in this study are standard.
Because vaginal discharge is considered normal in many developing countries and syndromic management requires accurate reporting of symptoms to clinicians, these findings may not be generalisable to women who are less likely to report vaginal symptoms. Nevertheless, the study also has strengths. The study investigators were skilled and experienced healthcare providers, and vaginal discharge symptoms were confirmed before any laboratory test. This could have led to an increase in the Se of the algorithm. We used risk assessment and speculum examination to improve the expected effectiveness of the algorithm, as stipulated by the WHO guidelines. Thus, findings from this study could be applied to non-pregnant women living in urban areas with complaints of vaginal symptoms who visit public health facilities.
Conclusion
The WHO syndromic algorithm for the management of vaginal discharge is a simple and cost-effective tool in settings where laboratory diagnosis is limited. This study highlights its limitations in settings with a low prevalence of STIs. Although large-scale studies are needed to confirm the effectiveness of the syndromic approach, our findings call for affordable and accurate rapid STI tests, particularly when TV, CT and NG are suspected.
